Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 38.5a

17 Nov 2015 12:10

RNS Number : 0111G
GoldmanSachs International
17 November 2015
 

Ap24

 

FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

(GS) GOLDMAN SACHS INTERNATIONAL

Company dealt in

PFIZER INC

Class of relevant security to which the dealings being disclosed relate (Note 1)

USD Ordinary

Date of dealing

16 November 2015

 

2. DEALINGS (Note 2)

 

(a) Purchases and sales

 

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid

(Note 3)

10,488

33.1477 USD

33.1477 USD

 

Total number of securities disposed

Highest price received (Note 3)

Lowest price received

(Note 3)

10,488

33.3500 USD

32.9300 USD

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit

(Note 3)

 

Ap25

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

Call Option / (1.00 : 100.00)

Purchasing

2 (200)

34.0000 USD

AMERICAN

20/11/2015

0.1600 USD

Call Option / (1.00 : 100.00)

Purchasing

12 (1,200)

36.0000 USD

AMERICAN

20/11/2015

0.0200 USD

Call Option / (1.00 : 100.00)

Purchasing

6 (600)

36.0000 USD

AMERICAN

20/11/2015

0.0200 USD

Put Option / (1.00 : 100.00)

Purchasing

3 (300)

32.0000 USD

AMERICAN

20/11/2015

0.1800 USD

Put Option / (1.00 : 100.00)

Purchasing

5 (500)

33.0000 USD

AMERICAN

20/11/2015

0.5000 USD

 

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)

 

3.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securitiesunder any option referred to on this form or relating to the voting rights or future acquisitionor disposal of any relevant securities to which any derivative referred to on this form is referenced.If none, this should be stated.

 

 

 

 

 

 

Date of disclosure

17 November 2015

Contact name

Aadithya Rao and Yiannis Bardis

Telephone number

+44(20) 7051 9046 / +44(20) 7774 7107

Name of offeree/offeror with which connected

Pfizer Inc

Nature of connection (Note 6)

Advisor to Offeror

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEEAAFXFEPSFFF
Date   Source Headline
6th Nov 20153:27 pmRNSForm 8.3 - Pfizer Inc
6th Nov 20153:25 pmRNSForm 8.3 - Pfizer Inc Amendment
6th Nov 20153:22 pmRNSForm 8.3 - Pfizer Inc
6th Nov 20153:19 pmRNSForm 8.3 - Allergan plc
6th Nov 20153:18 pmRNSForm 8.3 - Pfizer, Inc.
6th Nov 20153:15 pmBUSForm 8.3 - Pfizer Inc.
6th Nov 20153:04 pmRNSForm 8.3 - [PFIZER INC]
6th Nov 20152:52 pmRNSForm 8.3 - Pfizer Inc
6th Nov 20152:45 pmRNSForm 8.3 - Allergan Plc
6th Nov 20152:34 pmRNSForm 8.3 - ALLERGAN PLC
6th Nov 20152:03 pmRNSForm 8.3 - Pfizer Inc.
6th Nov 201512:57 pmRNSForm 38.5(b) - Pfizer Inc.
6th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc
6th Nov 201511:40 amRNSForm 38.5(a) - Pfizer Inc
6th Nov 201511:30 amRNSRule 38.5 - Pfizer INC
6th Nov 201511:15 amRNSForm 8.1 - [Pfizer]
6th Nov 201511:12 amRNSForm 38.5a
6th Nov 201511:12 amRNSForm 38.5b
6th Nov 201511:10 amRNSForm 38.5b
5th Nov 20154:32 pmRNSForm 8.3 - Pfizer, Inc.
5th Nov 20154:19 pmRNSRule 38.5 - Replacement Pfizer INC
5th Nov 20154:18 pmRNSForm 8.3 - Pfizer Inc
5th Nov 20154:16 pmRNSRule 38.5 - Replacement Pfizer INC
5th Nov 20154:15 pmRNSRule 38.5 - Replacement Pfizer INC
5th Nov 20153:35 pmRNSForm 8.3 - Pfizer Inc. - Amendment
5th Nov 20153:35 pmRNSForm 8.3 - Pfizer Inc.
5th Nov 20153:34 pmRNSForm 8.3 - Pfizer Inc
5th Nov 20153:30 pmRNSForm 8.3 - Allergan plc
5th Nov 20153:21 pmRNSForm 8.3 - [PFIZER INC]
5th Nov 20152:59 pmRNSForm 8.3 - Pfizer Inc
5th Nov 20152:53 pmBUSForm 8.3 - Pfizer Inc.
5th Nov 20152:43 pmRNSForm 8.3 - Allergan Plc
5th Nov 20152:14 pmRNSForm 8.3 - PFIZER INC
5th Nov 20152:12 pmRNSForm 8.3 - ALLERGAN PLC
5th Nov 201511:58 amRNSForm 38.5(b) - Pfizer Inc.
5th Nov 201511:49 amRNSForm 38.5b
5th Nov 201511:48 amRNSForm 38.5b
5th Nov 201511:47 amRNSForm 38.5b
5th Nov 201511:45 amRNSForm 38.5a
5th Nov 201511:45 amRNSForm 38.5a
5th Nov 201511:44 amRNSForm 8.1 - [Pfizer]
5th Nov 201511:39 amRNSForm 38.5(a) - Pfizer Inc.
5th Nov 201511:38 amRNSForm 38.5b
5th Nov 201511:26 amRNSRule 38.5 - Pfizer INC
5th Nov 201511:03 amRNSRule 38.5 - Pfizer INC
5th Nov 201511:01 amRNSRule 38.5 - Pfizer INC
4th Nov 20155:48 pmRNSRule 38.5 - Replacement Pfizer INC
4th Nov 20155:45 pmRNSRule 38.5 - Replacement Pfizer INC
4th Nov 20155:43 pmRNSRule 38.5 - Replacement Pfizer INC
4th Nov 20155:38 pmRNSRule 38.5 - Replacement Pfizer INC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.